Get started
Author

Ralf Spitthöver

Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular Disease: Prospective Observational Multicenter Study
2013 · Josef Leebmann, Eberhard Roeseler, et al. · Circulation · 334
PDF
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization
2016 · Eberhard Roeseler, Ulrich Julius, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 229
PDF
The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine
2001 · Heike Bruck, Mario Gössl, et al. · Journal of Hypertension · 35
Cardiovascular Outcome of Pediatric Patients With Bi-Allelic (Homozygous) Familial Hypercholesterolemia Before and After Initiation of Multimodal Lipid Lowering Therapy Including Lipoprotein Apheresis
2020 · Christina Taylan, Joenna Driemeyer, et al. · The American Journal of Cardiology · 22
Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis
2020 · Clemens Grupp, Johannes Beckermann, et al. · Blood Purification · 22
PDF
Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis
2019 · Ralf Spitthöver, Tilmann Röseler, et al. · Journal of Clinical Apheresis · 16
Treatment-related and health-related quality of life in lipoprotein apheresis patients
2018 · V. De Gucht, K. Cromm, et al. · Journal of clinical lipidology · 14
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity
2018 · Günter Klaus, Christina Taylan, et al. · Pediatric Nephrology · 14
Lipoprotein apheresis for lipoprotein(a)-associated progressive atherosclerotic cardiovascular disease: 12-years follow-up
2025 · Reinhard Klingel, Ulrich Julius, et al. · Atherosclerosis · 11
Safety aspects of lipidapheresis using DALI and MONET – Multicenter observational study
2017 · Justyna Kozik-Jaromin, Eberhard Röseler, et al. · Atherosclerosis Supplements · 10
Binding and detoxification efficiency of albumin decline after haemodialysis
2023 · Kristina Boss, Katja Waterstradt, et al. · Nephrology Dialysis Transplantation · 8
PDF
Efficacy of lipid reduction with DALI and MONET
2017 · Wolfgang Ramlow, Eberhard Röseler, et al. · Atherosclerosis Supplements · 8
Recurrent neurovascular hypertension: MR findings before and after surgical treatments.
2001 · E R Gizewski, R M Spitthöver, et al. · PubMed · 8
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
2023 · Kristina Boss, Margret Paar, et al. · BMC Nephrology · 6
PDF
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study
2022 · Ulrich Laufs, Andreas L. Birkenfeld, et al. · Cardiovascular Drugs and Therapy · 6
PDF
Predictive role of fluctuating biochemical parameters for mortality in hemodialysis patients
2022 · Nils Mülling, Jan ter Huurne, et al. · Therapeutic Apheresis and Dialysis · 3
PDF
Impact of severe dyslipidemia on renal function: A cross-sectional study
2025 · Nicole Lewandowski, Walter Reinhardt, et al. · Medicine · 2
[Renal artery stenosis].
2000 · R R Wenzel, R Spitthöver, et al. · PubMed · 1
Zielwertorientierte lipidsenkende Therapie: Bedeutung für die periphere arterielle Verschlusserkrankung
2021 · Ralf Spitthöver, Reinhard Klingel, et al. · Gefässchirurgie
Supplementary Material for: Relapsing and Progressive Complications of Severe Hypertriglyceridemia: Effective Long-Term Treatment with Double Filtration Plasmapheresis
2020 · Grupp, C., Beckermann, J., et al. · Figshare
Moxonidine Reduces the Basal Tone of Sns Activity Without an Additional Effect on Exercise and Mental Stress Induced Sns Activation
2000 · R. R. Wenzel, J. Nürnberger, et al. · Journal of Hypertension
Endothelin-a-receptor Antagonist Inhibits Angiotensin Ii and Noradrenaline Induced Vaso-constriction in Human Skin Microcirculation in Vivo
2000 · R. R. Wenzel, J. Rüthemann, et al. · Journal of Hypertension
Works count: 24
Citation count: 749
H-index: 10
I10-index: 10
Year
Topic
Type